Epipodophyllotoxins and secondary leukemia.
Womer
R B
RB
Division of Oncology, Children's Hospital of Philadelphia.
D002648:Child; D005260:Female; D015616:Histiocytosis, Non-Langerhans-Cell / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D008297:Male; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D011034:Podophyllotoxin / Q000009:adverse effects*; D013713:Teniposide / Q000009:adverse effects
D013713:Teniposide; D011034:Podophyllotoxin